603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration

Bibliographic Details
Title: 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration
Authors: David Jackson, Shelley Ackerman, David Dornan, Michael Alonso, Felix Hartmann, Cecelia Pearson, Joseph Gonzalez, Po Yi Ho, Samuel Kimmey, Andrew Luo, Benjamin Ackerman, Arthur Lee, Richard Laura, Jason Paik, Karla Henning, Steven Chapin, Bruce Devens, Sean Bendall, Edgar Engleman
Source: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Publisher Information: BMJ Publishing Group, 2020.
Publication Year: 2020
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2051-1426
Relation: https://doaj.org/toc/2051-1426
DOI: 10.1136/jitc-2020-SITC2020.0603
Access URL: https://doaj.org/article/f5d7558c062d476da010b826729b37c4
Accession Number: edsdoj.f5d7558c062d476da010b826729b37c4
Database: Directory of Open Access Journals
More Details
ISSN:20511426
DOI:10.1136/jitc-2020-SITC2020.0603
Published in:Journal for ImmunoTherapy of Cancer
Language:English